Cargando…

Prognostication using SpO(2)/FiO(2) in invasively ventilated ICU patients with ARDS due to COVID-19 – Insights from the PRoVENT-COVID study()

BACKGROUND: The SpO(2)/FiO(2) is a useful oxygenation parameter with prognostic capacity in patients with ARDS. We investigated the prognostic capacity of SpO(2)/FiO(2) for mortality in patients with ARDS due to COVID–19. METHODS: This was a post-hoc analysis of a national multicenter cohort study i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roozeman, Jan-Paul, Mazzinari, Guido, Serpa Neto, Ary, Hollmann, Markus W., Paulus, Frederique, Schultz, Marcus J., Pisani, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641962/ https://www.ncbi.nlm.nih.gov/pubmed/34872014 http://dx.doi.org/10.1016/j.jcrc.2021.11.009

Ejemplares similares

Risk stratification using SpO(2)/FiO(2) and PEEP at initial ARDS diagnosis and after 24 h in patients with moderate or severe ARDS
por: Pisani, Luigi, et al.
Publicado: (2017)

Association of Time–Varying Intensity of Ventilation With Mortality in Patients With COVID−19 ARDS: Secondary Analysis of the PRoVENT–COVID Study
por: Schuijt, Michiel T. U., et al.
Publicado: (2021)

Mortality associated with early changes in ARDS severity in COVID–19 patients – Insights from the PRoVENT–COVID study
por: Schuijt, Michiel T.U., et al.
Publicado: (2021)

Correlation of SpO(2)/FiO(2) and PaO(2)/FiO(2) in patients with symptomatic COVID-19: An observational, retrospective study
por: Bonaventura, Aldo, et al.
Publicado: (2022)

ARDS diagnosed by SpO(2)/FiO(2) ratio compared with PaO(2)/FiO(2) ratio: the role as a diagnostic tool for early enrolment into clinical trials
por: Wiedermann, Franz J., et al.
Publicado: (2016)

Correlation of the SpO(2)/FiO(2) (S/F) ratio and the PaO(2)/FiO(2) (P/F) ratio in patients with COVID-19 pneumonia
por: Kumar, A., et al.
Publicado: (2022)

Correlation of the SpO(2)/FiO(2) (S/F) ratio and the PaO(2)/FiO(2) (P/F) ratio in patients with COVID-19 pneumonia
por: Kumar, A., et al.
Publicado: (2022)

Association between SpO(2)/FiO(2) Ratio and PaO(2)/FiO(2) Ratio in Different Modes of Oxygen Supplementation
por: Babu, Sheetal, et al.
Publicado: (2021)

Associations of Body Mass Index with Ventilation Management and Clinical Outcomes in Invasively Ventilated Patients with ARDS Related to COVID-19—Insights from the PRoVENT-COVID Study
por: Schavemaker, Renée, et al.
Publicado: (2021)

Sex Differences in Use of Low Tidal Volume Ventilation in COVID-19—Insights From the PRoVENT–COVID Study
por: Swart, Pien, et al.
Publicado: (2022)

Determination of SpO(2)/FiO(2 )thresholds to impute for PaO(2)/FiO(2 )ratios in the Sequential Organ Failure Assessment score
por: Pandharipande, P, et al.
Publicado: (2008)

Rationale and limitations of the SpO(2)/FiO(2) as a possible substitute for PaO(2)/FiO(2) in different preclinical and clinical scenarios
por: de Carvalho, Eduardo Butturini, et al.
Publicado: (2022)

Association of intensity of ventilation with 28-day mortality in COVID-19 patients with acute respiratory failure: insights from the PRoVENT-COVID study
por: Schuijt, Michiel T. U., et al.
Publicado: (2021)

Low tidal volume ventilation is associated with mortality in COVID-19 patients—Insights from the PRoVENT-COVID study
por: Nijbroek, Sunny G.L.H., et al.
Publicado: (2022)

Relation between PaO(2)/FiO(2 )ratio, SpO(2)/FiO(2 )ratio, oxygenation index and ventilation ratio in critically ill patients
por: Aslanidis, T, et al.
Publicado: (2013)

Utility of SpO(2)/FiO(2) ratio for acute hypoxemic respiratory failure with bilateral opacities in the ICU
por: Fukuda, Yosuke, et al.
Publicado: (2021)

The effect of age on ventilation management and clinical outcomes in critically ill COVID–19 patients––insights from the PRoVENT–COVID study
por: Hol, Liselotte, et al.
Publicado: (2022)

Potentially modifiable respiratory variables contributing to outcome in ICU patients without ARDS: a secondary analysis of PRoVENT
por: Simonis, Fabienne D., et al.
Publicado: (2018)

Assessment of the SpO(2)/FiO(2) ratio as a tool for hypoxemia screening in the emergency department
por: Catoire, Pierre, et al.
Publicado: (2021)

Incidence and Practice of Early Prone Positioning in Invasively Ventilated COVID-19 Patients—Insights from the PRoVENT-COVID Observational Study
por: Stilma, Willemke, et al.
Publicado: (2021)

Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study
por: Botta, Michela, et al.
Publicado: (2021)

Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients — insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysis
por: Ahuja, Sanchit, et al.
Publicado: (2022)

PRactice of VENTilation in Patients with Novel Coronavirus Disease (PRoVENT-COVID): rationale and protocol for a national multicenter observational study in The Netherlands
por: Boers, Noor S., et al.
Publicado: (2020)

Epidemiology, Ventilation Management and Outcomes of COPD Patients Receiving Invasive Ventilation for COVID-19—Insights from PRoVENT-COVID
por: Tripipitsiriwat, Athiwat, et al.
Publicado: (2023)

Is it time to revisit the PaO(2)/FiO(2) ratio to define the severity of oxygenation in ARDS?
por: Palanidurai, Sunitha, et al.
Publicado: (2021)

Incorporating ventilatory support parameters into the PaO(2)/FiO(2) ratio in ARDS patients
por: El-Khatib, Mohamad F., et al.
Publicado: (2021)

Clinical characteristics, physiological features, and outcomes associated with hypercapnia in patients with acute hypoxemic respiratory failure due to COVID–19---insights from the PRoVENT–COVID study
por: Tsonas, Anissa M., et al.
Publicado: (2022)

The Use of the SpO(2) to FiO(2) Ratio to Individualize the Hypoxic Dose in Sport Science, Exercise, and Health Settings
por: Soo, Jacky, et al.
Publicado: (2020)

Variation in the PaO(2)/FiO(2 )ratio with FiO(2): mathematical and experimental description, and clinical relevance
por: Karbing, Dan S, et al.
Publicado: (2007)

Continuously available ratio of SpO(2)/FiO(2) serves as a noninvasive prognostic marker for intensive care patients with COVID-19
por: Lu, Xiaofan, et al.
Publicado: (2020)

Impact of Air Transport on SpO(2)/FiO(2) among Critical COVID-19 Patients during the First Pandemic Wave in France
por: Bouillon-Minois, Jean-Baptiste, et al.
Publicado: (2021)

Determination of PaO2/FiO2 after 24 h of invasive mechanical ventilation and ΔPaO2/FiO2 at 24 h as predictors of survival in patients diagnosed with ARDS due to COVID-19
por: Hueda-Zavaleta, Miguel, et al.
Publicado: (2022)

Automated FiO(2)-SpO(2) control system in Neonates requiring respiratory support: a comparison of a standard to a narrow SpO(2) control range
por: Wilinska, Maria, et al.
Publicado: (2014)

Correlation of non-invasive oxygenation parameters with paO2/FiO2 ratio in patients with COVID-19 associated ARDS
por: Zaccagnini, Giacomo, et al.
Publicado: (2022)

Evaluation of two SpO(2) alarm strategies during automated FiO(2) control in the NICU: a randomized crossover study
por: Warakomska, Malgorzata, et al.
Publicado: (2019)

SpO(2)/FiO(2) as a predictor of high flow nasal cannula outcomes in children with acute hypoxemic respiratory failure
por: Kim, Ga Eun, et al.
Publicado: (2021)

Expanding Use of the ProVent Score
por: Jeon, Kyeongman
Publicado: (2019)

PEEP-FiO(2) table versus EIT to titrate PEEP in mechanically ventilated patients with COVID-19-related ARDS
por: Somhorst, Peter, et al.
Publicado: (2022)

Practice of tracheostomy in patients with acute respiratory failure related to COVID–19 – Insights from the PRoVENT–COVID study
por: Tsonas, A.M., et al.
Publicado: (2022)

Clinical relevance of the PaO(2)/FiO(2 )ratio
por: El-Khatib, Mohamad F, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_gd4ep9vk3p12grt2dc588r1rbo